Retraction
Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas
Paper Information
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9853753Additional Notes:
See also: https://pubpeer.com/publications/741B4BA2EC6D712E7F6E81BACB1572
Citations (3)
3
Total Citations1
Post-Retraction(33.3%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
43
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Efficacy of apatinib combined with temozolomide in the treatment of recurrent high‑grade glioma: A meta‑analysis
Guanglie Li, Xiwei Xu, Jianqi Cui et al. (5 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Aug 2023
1 citation
1 citation
43 days after retraction
Retracted: Low‐Dose Apatinib Improves the Prognosis of Patients with Recurrent High‐Grade Gliomas
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
171 days before retraction
Quick Stats
Total Citations:
3
Years Since Retraction:
2.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025